Back
Calidi Biotherapeutics Stock Price Chart
Buy
74
CLDI
Calidi Biotherapeutics
Last Price:
0.19
Seasonality Move:
-13.27%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLDI is experiencing selling pressure, which indicates risk of future bearish movement.
Calidi Biotherapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.25 | Buy |
20-day SMA: | 0.23 | Buy |
50-day SMA: | 0.34 | Sell |
200-day SMA: | 2.15 | Sell |
8-day EMA: | 0.26 | Buy |
20-day EMA: | 0.25 | Buy |
50-day EMA: | 0.37 | Sell |
200-day EMA: | 2.44 | Sell |
Calidi Biotherapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 56.1 | Buy |
Chaikin Money Flow: | -5294137 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.19 - 0.25) | Buy |
Bollinger Bands (100): | (0.25 - 0.93) | Sell |
Calidi Biotherapeutics Technical Analysis
May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
16 | 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Calidi Biotherapeutics Stock
Is Calidi Biotherapeutics Stock a Buy?
- Calidi Biotherapeutics share price is 0.30 while CLDI 8-day simple moving average is 0.25, which is a Buy signal.
- The stock price of CLDI is 0.30 while Calidi Biotherapeutics 20-day SMA is 0.23, which makes it a Buy.
- Calidi Biotherapeutics 50-day simple moving average is 0.34 while CLDI share price is 0.30, making it a Sell technically.
- CLDI stock price is 0.30 and Calidi Biotherapeutics 200-day simple moving average is 2.15, creating a Sell signal.
CLDI Technical Analysis vs Fundamental Analysis
Buy
74
Calidi Biotherapeutics (CLDI)
is a Buy
Is Calidi Biotherapeutics a Buy or a Sell?
-
Calidi Biotherapeutics stock is rated a Buy
The current Calidi Biotherapeutics [CLDI] share price is $0.30. The Score for CLDI is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
Calidi Biotherapeutics Stock Info
Market Cap:
15.28M
Price in USD:
0.30
Share Volume:
9M
Calidi Biotherapeutics 52-Week Range
52-Week High:
13.79
52-Week Low:
0.14
Buy
74
Calidi Biotherapeutics (CLDI)
is a Buy
Calidi Biotherapeutics Share Price Forecast
-
What is the Calidi Biotherapeutics stock price today?
The Calidi Biotherapeutics stock price is 0.30 USD today. -
Will CLDI stock go up or go down?
Calidi Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Calidi Biotherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Calidi Biotherapeutics is not overvalued.
Is Calidi Biotherapeutics Stock a Buy?
- Calidi Biotherapeutics share price is 0.30 while CLDI 8-day exponential moving average is 0.26, which is a Buy signal.
- The stock price of CLDI is 0.30 while Calidi Biotherapeutics 20-day EMA is 0.25, which makes it a Buy.
- Calidi Biotherapeutics 50-day exponential moving average is 0.37 while CLDI share price is 0.30, making it a Sell technically.
- CLDI stock price is 0.30 and Calidi Biotherapeutics 200-day simple moving average is 2.44, creating a Sell signal.
Fundamental Analysis of Calidi Biotherapeutics
Is Calidi Biotherapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and an increase next year of $0.29 per share.
Technical Analysis of Calidi Biotherapeutics
Should I short Calidi Biotherapeutics stock?
- CLDI Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Calidi Biotherapeutics is a Sell
- Calidi Biotherapeutics Relative Strength Index (RSI) is 56.1, which suggest Calidi Biotherapeutics is overbought
- The Bollinger Bands (25) for Calidi Biotherapeutics is (0.19 - 0.25), which suggest Calidi Biotherapeutics is a Sell
- The Bollinger Bands (100) for Calidi Biotherapeutics is (0.25 - 0.93), which suggest Calidi Biotherapeutics is a Sell
* Calidi Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.